Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Database Study for Rivaroxaban in Patients With PAD After Lower Limb Revascularization.

NCT07142655 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT07142655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07142655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Database Study for Rivaroxaban in Patients With PAD After Lower Limb Revascularization.
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
August 12, 2025
Completion date
March 9, 2026
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease (pad)